Autoimmune hemolytic anemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Autoimmune hemolytic anemia}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Autoimmune_hemolytic_anemia]]


{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]; {{shyam}}, [[User:Irfan Dotani|Irfan Dotani]] [3]
{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]; {{shyam}}, [[User:Irfan Dotani|Irfan Dotani]] [3]
Line 33: Line 33:
!Ferritin
!Ferritin
!% Transferrin saturation
!% Transferrin saturation
|-
!Autoimmune  hemolytic anemia
|
* [[Normocytic anemia|Normocytic]]
|
* + ([[Intravascular]])
|
* Extrinsic
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
* Painful blue fingers and toes on exposure to cold temperature.
* [[Chest pain]]
* [[Rigor|Chills]]
* [[Dizziness]]
* [[Tachycardia]]
* [[Headache]]
* [[Fatigue]]
|Associated with:
* SLE
* CLL
* Mycoplasia pneumoniae infection
|
* Painful, blue fingers and toes with cold weather
|<nowiki>--</nowiki>
|
* Normal
|
* ↓(Decreased)
|
* Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
* RBC agglutination
|-
|-
!Iron deficiency anemia  
!Iron deficiency anemia  
|[[Microcytic anemia|Microcytic]]
|
* [[Microcytic anemia|Microcytic]]
| --
| --
| --
| --
|[[Hypochromic anemia|Hypochromic]]
|
|↑
* [[Hypochromic anemia|Hypochromic]]
|Normal or ↓(Decreased)
|
|Normal
* (Increased)
|
* Normal or ↓(Decreased)
|
* Normal
|
|
* [[Koilonychia]]
* [[Koilonychia]]
Line 55: Line 102:
* [[Dysphagia]]
* [[Dysphagia]]
| --
| --
|Normal
|
|↓(Decreased)
* Normal
|↑(Increased)
|
|↑(Increased)
* ↓(Decreased)
|↓(Decreased)
|
|↓↓↓(Decreased)
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
* ↓↓↓(Decreased)
|
|
* Central [[pallor]]
* Central [[pallor]]
|-
|-
!Lead poisoning  
!Lead poisoning  
|[[Microcytic anemia|Microcytic]]
|
* [[Microcytic anemia|Microcytic]]
| --
| --
| --
| --
|[[Intravascular|Hypochromic]]
|
|Normal
* [[Intravascular|Hypochromic]]
|Normal or ↓(Decreased)
|
|Normal
* Normal
|
* Normal or ↓(Decreased)
|
* Normal
|
|
* Burtonian lines
* Burtonian lines
Line 84: Line 142:
* Burtonian lines
* Burtonian lines
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|Normal to low
* Normal
|Normal
|
|Normal
* Normal or ↓(Decreased)
|Normal to low
|
* Normal
|
* Normal
|
* Normal or ↓(Decreased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
Line 94: Line 157:
|-
|-
!Sideroblastic anemia
!Sideroblastic anemia
|[[Microcytic anemia|Microcytic]]
|
* [[Microcytic anemia|Microcytic]]
| --
| --
| --
| --
|[[Hypochromic anemia|Hypochromic]]
|
|Normal
* [[Hypochromic anemia|Hypochromic]]
|Normal or ↓(Decreased)
|
|Normal
* Normal
|
* Normal or ↓(Decreased)
|
* Normal
|
|
* [[Seborrheic dermatitis]]
* [[Seborrheic dermatitis]]
Line 119: Line 187:
* [[Autosomal recessive]]  
* [[Autosomal recessive]]  
* [[X-linked]]
* [[X-linked]]
|Normal
|
|↑(Increased)
* Normal
|normal
|
|Normal/↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
* Normal
|
* Normal or ↓(Decreased)
|
* ↑(Increased)
| --
| --
|
|
Line 129: Line 202:
|-
|-
!Anemia of chronic disease  
!Anemia of chronic disease  
|[[Microcytic anemia|Microcytic]]
|
* [[Microcytic anemia|Microcytic]]
| --
| --
| --
| --
|[[Hypochromic anemia|Hypochromic]]
|
|Normal
* [[Hypochromic anemia|Hypochromic]]
|Normal or ↓(Decreased)
|
|Normal
* Normal
|
* Normal or ↓(Decreased)
|
* Normal
|
|
* [[Headache]]
* [[Headache]]
Line 146: Line 224:
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
| --
| --
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|Normal
|
|↓(Decreased)
* ↓(Decreased)
|↑(Increased)
|
* Normal
|
* ↓(Decreased)
|
* ↑(Increased)
| --
| --
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|-
|-
!Thalassemia
!Thalassemia
|[[Microcytic anemia|Microcytic]]
|
* [[Microcytic anemia|Microcytic]]
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
| --
| --
|[[Hypochromic anemia|Hypochromic]]
|
|Normal  
* [[Hypochromic anemia|Hypochromic]]
|
* Normal
|
|
* '''Thalassemia trait'''
* '''Thalassemia trait'''
Line 166: Line 252:
↑(Increased)
↑(Increased)


|Normal
|
* Normal
|'''α-thalassemia'''
|'''α-thalassemia'''
* [[Hydrops fetalis]]
* [[Hydrops fetalis]]
Line 183: Line 270:
'''β-thalassemia'''
'''β-thalassemia'''
* [[Point mutation]] in [[Splice site|splice sites]] and promoter sequences
* [[Point mutation]] in [[Splice site|splice sites]] and promoter sequences
|Normal
|
|Normal to ↑(Increased)
* Normal
|Normal
|
|Normal
* Normal to ↑(Increased)
|↑(Increased)
|
* Normal
|
* Normal
|
* ↑(Increased)
|Normal to increased  
|Normal to increased  
|
|
Line 194: Line 286:
|-
|-
!G6pd deficiency
!G6pd deficiency
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|↑(Increased)
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
|
* ↑(Increased) but usually causes resolution within 4-7 days
* ↑(Increased) but usually causes resolution within 4-7 days
|↓(Decreased)
|
* ↓(Decreased)
|
|
* [[Back pain]]
* [[Back pain]]
Line 215: Line 313:
* Defect in [[Glucose-6-phosphate dehydrogenase|G6PD]] enzyme
* Defect in [[Glucose-6-phosphate dehydrogenase|G6PD]] enzyme
* X-Linked [[recessive]]
* X-Linked [[recessive]]
|↓(Decreased)
|
|Normal to↑(Increased)
* ↓(Decreased)
|Normal
|
|↑(Increased)
* Normal to ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* Normal
|
* ↑(Increased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* RBC with [[Heinz bodies]]
* RBC with [[Heinz bodies]]
Line 228: Line 332:
|-
|-
!Pyruvate Kinase deficiency
!Pyruvate Kinase deficiency
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|↑(Increased)
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* ↓(Decreased)
|
|
* [[Hydrops fetalis]]
* [[Hydrops fetalis]]
Line 249: Line 359:
*  Mutation in the ''[[PKLR]]'' and PKM gene mutations
*  Mutation in the ''[[PKLR]]'' and PKM gene mutations
* [[Autosomal recessive]]
* [[Autosomal recessive]]
|Normal
|
|↑(Increased)
* Normal
|Normal
|
|Normal
* ↑(Increased)
|↑(Increased)
|
* Normal
|
* Normal
|
* ↑(Increased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
Line 260: Line 375:
|-
|-
!Sickle cell anemia
!Sickle cell anemia
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|↑(Increased)
|
|↑(Increased)
* Intrinsic
|↓(Decreased)
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* Painful crisis
* Painful crisis
Line 289: Line 411:
* Hbs [[point mutation]] causes a single [[Amino acid|amino]]  [[Amino acid|acid]] replacement in β chain
* Hbs [[point mutation]] causes a single [[Amino acid|amino]]  [[Amino acid|acid]] replacement in β chain
|Normal or moderately elevated
|Normal or moderately elevated
|normal
|
|Normal
* Normal
|
* Normal
|Normal or moderately elevated
|Normal or moderately elevated
|↓(Decreased)
|
|Normal  
* ↓(Decreased)
|
* Normal
|
|
* Increased [[erythropoiesis]]
* Increased [[erythropoiesis]]
Line 300: Line 426:
|-
|-
!HbC disease  
!HbC disease  
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|↑(Increased)
|
|↑(Increased)
* Intrinsic
|↓(Decreased)
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* [[Splenomegaly]]
* [[Splenomegaly]]
Line 320: Line 453:
* Glutamic acid–to-lysine mutation in
* Glutamic acid–to-lysine mutation in
β-globin
β-globin
|Normal
|
|normal
* Normal
|Normal
|
|Normal  
* Normal
|↓(Decreased)
|
* Normal
|
* Normal
|
* ↓(Decreased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
Line 331: Line 469:
|-
|-
!Paroxysmal nocturnal hemoglobinuria(PNH)<ref name="pmid1402472">{{cite journal |vauthors=Bunyaratvej A, Butthep P |title=Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes |journal=J Med Assoc Thai |volume=75 Suppl 1 |issue= |pages=237–42 |date=January 1992 |pmid=1402472 |doi= |url=}}</ref><ref name="pmid25553278">{{cite journal |vauthors=Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K |title=A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data |journal=Ann Lab Med |volume=35 |issue=1 |pages=35–40 |date=January 2015 |pmid=25553278 |pmc=4272963 |doi=10.3343/alm.2015.35.1.35 |url=}}</ref>
!Paroxysmal nocturnal hemoglobinuria(PNH)<ref name="pmid1402472">{{cite journal |vauthors=Bunyaratvej A, Butthep P |title=Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes |journal=J Med Assoc Thai |volume=75 Suppl 1 |issue= |pages=237–42 |date=January 1992 |pmid=1402472 |doi= |url=}}</ref><ref name="pmid25553278">{{cite journal |vauthors=Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K |title=A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data |journal=Ann Lab Med |volume=35 |issue=1 |pages=35–40 |date=January 2015 |pmid=25553278 |pmc=4272963 |doi=10.3343/alm.2015.35.1.35 |url=}}</ref>
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|↑(Increased)
|
|↑(Increased)
* Intrinsic
|↓(Decreased)
|
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* [[Hemolysis|Chronic hemolysis]]
* [[Hemolysis|Chronic hemolysis]]
Line 356: Line 501:
* Impaired  synthesis of [[GPI anchor]] for decay-accelerating  factor [DAF/[[CD55]]] and membrane inhibitor  of reactive lysis [MIRL/[[CD59]]]
* Impaired  synthesis of [[GPI anchor]] for decay-accelerating  factor [DAF/[[CD55]]] and membrane inhibitor  of reactive lysis [MIRL/[[CD59]]]


|Normal
|
|↓(Decreased)
* Normal
|Normal
|
|↑(Increased)
* ↓(Decreased)
|↓(Decreased)
|
* Normal
|
* ↑(Increased)
|
* ↓(Decreased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|-
|-
!Hereditary spherocytosis
!Hereditary spherocytosis
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Intrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
|
* ↑(Increased)
* ↑(Increased)
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* ↓(Decreased)
|
|
* [[Splenomegaly]]  
* [[Splenomegaly]]  
Line 385: Line 540:
|
|
* Mutations in [[Ankyrin]],[[Band 3]], [[Protein 4.2]] and [[spectrin]]
* Mutations in [[Ankyrin]],[[Band 3]], [[Protein 4.2]] and [[spectrin]]
|Normal
|
|↓(Decreased)
* Normal
|Normal
|
|↑(Increased)
* ↓(Decreased)
|Normal
|
* Normal
|
* ↑(Increased)
|
* Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
Line 396: Line 556:
|-
|-
!Microangiopathic hemolytic anemia<ref name="pmid26251142">{{cite journal |vauthors=Morishita E |title=[Diagnosis and treatment of microangiopathic hemolytic anemia] |language=Japanese |journal=Rinsho Ketsueki |volume=56 |issue=7 |pages=795–806 |date=July 2015 |pmid=26251142 |doi=10.11406/rinketsu.56.795 |url=}}</ref>  
!Microangiopathic hemolytic anemia<ref name="pmid26251142">{{cite journal |vauthors=Morishita E |title=[Diagnosis and treatment of microangiopathic hemolytic anemia] |language=Japanese |journal=Rinsho Ketsueki |volume=56 |issue=7 |pages=795–806 |date=July 2015 |pmid=26251142 |doi=10.11406/rinketsu.56.795 |url=}}</ref>  
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Extrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
|
* ↑(Increased)
* ↑(Increased)
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* ↓(Decreased)
|
|
* Purpura
* Purpura
Line 423: Line 588:
* Pale conjunctiva
* Pale conjunctiva
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|↓(Decreased)
* Normal
|Normal
|
* ↓(Decreased)
|
* Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|↑(Increased)
|
* ↑(Increased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
Line 433: Line 602:
|-
|-
!Macroangiopathic hemolytic anemia  
!Macroangiopathic hemolytic anemia  
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Extrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
|
* ↑(Increased)
* ↑(Increased)
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* ↓(Decreased)
|
|
* [[Pallor]]
* [[Pallor]]
Line 454: Line 628:
|
|
* Autoimmune  
* Autoimmune  
|Normal
|
|↓(Decreased)
* Normal
|Normal
|
* ↓(Decreased)
|
* Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
Line 464: Line 641:
|-
|-
!Infections
!Infections
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Extrinsic
|
|[[Normochromic anemia|Normochromic]]
* + ([[Intravascular]])
|
* Intrinsic
|
* [[Normochromic anemia|Normochromic]]
|
|
* ↑(Increased)
* ↑(Increased)
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* ↓(Decreased)
|
|
* [[Fever]]
* [[Fever]]
Line 483: Line 665:
* Headache
* Headache
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|Normal
* Normal
|Normal
|
* Normal
|
* Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
Line 493: Line 678:
* Maltese crosses  
* Maltese crosses  
|-
|-
!Autoimmune  hemolytic anemia  
!Iron deficiency anemia(Early)
|[[Normocytic anemia|Normocytic]]
|
| + ([[Intravascular]])
* [[Normocytic anemia|Normocytic]]
|Extrinsic
| --
|[[Normochromic anemia|Normochromic]]
| --
|
|
* ↑(Increased)
* [[Normochromic anemia|Normochromic]]
|
|
* ↑(Increased)
* ↑(Increased)
|↓(Decreased)
|
* Painful blue fingers and toes on exposure to cold temperature.
* [[Chest pain]]
* [[Rigor|Chills]]
* [[Dizziness]]
* [[Tachycardia]]
* [[Headache]]
* [[Fatigue]]
|Associated with:
* SLE
* CLL
* Mycoplasia pneumoniae infection
|
|
* Painful, blue fingers and toes with cold weather
* ↓(Decreased)
|<nowiki>--</nowiki>
|Normal
|↓(Decreased)
|Normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|
|
* RBC agglutination
* Normal
|-
!Iron deficiency anemia(Early)
|[[Normocytic anemia|Normocytic]]
| --
| --
|[[Normochromic anemia|Normochromic]]
|↑(Increased)
|↓(Decreased)
|Normal
|
|
* [[Fatigue]]
* [[Fatigue]]
Line 547: Line 703:
* Dry skin
* Dry skin
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|↓(Decreased)
* Normal
|↑(Increased)
|
|↑(Increased)
* ↓(Decreased)
|↓(Decreased)
|
|↓(Decreased)
* ↑(Increased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
* ↓(Decreased)
|
|
* Microcytosis
* Microcytosis
Line 560: Line 722:
|-
|-
!Anemia of chronic disease
!Anemia of chronic disease
|[[Normocytic anemia|Normocytic]]
|
* [[Normocytic anemia|Normocytic]]
| --
| --
| --
| --
|[[Normochromic anemia|Normochromic]]
|
|Normal
* [[Normochromic anemia|Normochromic]]
|
* Normal
|Normal or ↓(Decreased)
|Normal or ↓(Decreased)
|Normal
|
* Normal
|
|
* [[Fatigue]]
* [[Fatigue]]
Line 578: Line 744:
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↓(Decreased)
* ↓(Decreased)
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* Normocytic cells but may become microcytic
* Normocytic cells but may become microcytic
|-
|-
!Aplastic anemia
!Aplastic anemia
|[[Normocytic anemia|Normocytic]]
|
* [[Normocytic anemia|Normocytic]]
| --
| --
| --
| --
|[[Normochromic anemia|Normochromic]]
|
|↑(Increased)
* [[Normochromic anemia|Normochromic]]
|↓(Decreased)
|
|Normal
* ↑(Increased)
|
* ↓(Decreased)
|
* Normal
|
|
* Symptoms based on underlying condition
* Symptoms based on underlying condition
Line 612: Line 789:
* Mutations in the perforin gene
* Mutations in the perforin gene
* Mutations in ''SAP gene''
* Mutations in ''SAP gene''
|Normal
|
|↓(Decreased)
* Normal
|↓(Decreased)
|
|Normal
* ↓(Decreased)
|↑(Increased)
|
|↓(Decreased)
* ↓(Decreased)
|
* Normal
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* [[Pancytopenia]]
* [[Pancytopenia]]
Line 623: Line 806:
|-
|-
!Chronic kidney disease
!Chronic kidney disease
|[[Normocytic anemia|Normocytic]]
|
* [[Normocytic anemia|Normocytic]]
| --
| --
| --
| --
|[[Normochromic anemia|Normochromic]]
|
|↑(Increased)
* [[Normochromic anemia|Normochromic]]
|
* ↑(Increased)
|Normal /↑(Increased)
|Normal /↑(Increased)
|Normal
|
* Normal
|
|
* [[Polyuria]]
* [[Polyuria]]
Line 644: Line 831:
* Mostly normal
* Mostly normal
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|
* ↓(Decreased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|↓(Decreased)
|
|↑(Increased)
* ↓(Decreased)
|↓(Decreased)
|
* ↑(Increased)
|
* ↓(Decreased)
|
|
* Normal
* Normal
|-
|-
!Folate deficiency  
!Folate deficiency  
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic  
|
|↑(Increased)
* Anisochromic
|↓(Decreased)
|
|Normal
* ↑(Increased)
|
* ↓(Decreased)
|
* Normal
|
|
* No neurological symptoms vs [[Vitamin B12 deficiency|B12 deficiency]]
* No neurological symptoms vs [[Vitamin B12 deficiency|B12 deficiency]]
Line 677: Line 874:
|
|
* Impaired [[DNA]] synthesis
* Impaired [[DNA]] synthesis
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* [[Macrocytosis|RBC macrocytosis]]
* [[Macrocytosis|RBC macrocytosis]]
Line 690: Line 893:
|-
|-
!Vitamin B12 deficiency
!Vitamin B12 deficiency
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
|↑(Increased)
* Anisochromic
|↓(Decreased)
|
|Normal
* ↑(Increased)
|
* ↓(Decreased)
|
* Normal
|
|
* [[Psychosis]]
* [[Psychosis]]
Line 718: Line 926:
|
|
* Impaired DNA synthesis
* Impaired DNA synthesis
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* [[Senile]] [[neutrophil]]
* [[Senile]] [[neutrophil]]
Line 730: Line 944:
|-
|-
!Orotic aciduria
!Orotic aciduria
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
|↑(Increased)
* Anisochromic
|↓(Decreased)
|
|Normal
* ↑(Increased)
|
* ↓(Decreased)
|
* Normal
|
|
* Coma
* Coma
Line 748: Line 967:
* [[Autosomal recessive]]
* [[Autosomal recessive]]
* Deficiency of enzyme UMPS
* Deficiency of enzyme UMPS
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
| --
| --
|-
|-
!Fanconi anemia
!Fanconi anemia
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
|↑(Increased)
* Anisochromic
|↓(Decreased)
|
|Normal
* ↑(Increased)
|
* ↓(Decreased)
|
* Normal
|
|
* [[Hypopigmentation]]
* [[Hypopigmentation]]
Line 775: Line 1,005:
* [[Autosomal recessive]]
* [[Autosomal recessive]]
* [[X-linked recessive]]
* [[X-linked recessive]]
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* Normal appearing WBC, RBC and Platelets
* Normal appearing WBC, RBC and Platelets
Line 786: Line 1,022:
|-
|-
!Diamond-Blackfan anemia
!Diamond-Blackfan anemia
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
* Anisochromic
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|↓(Decreased)
|
|Normal
* ↓(Decreased)
|
* Normal
|
|
* [[Pale skin]]
* [[Pale skin]]
Line 817: Line 1,057:
* RPS24
* RPS24
* RPS26
* RPS26
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|-
|-
!Liver disease  
!Liver disease  
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
|↑(Increased)
* Anisochromic
|↑(Increased)
|
|Normal
* ↑(Increased)
|
* ↑(Increased)
|
* Normal
|
|
* [[Jaundice]]
* [[Jaundice]]
Line 848: Line 1,099:
* [[Ankle swelling]]
* [[Ankle swelling]]
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* [[Macrocyte|Round macrocytes]]
* [[Macrocyte|Round macrocytes]]
Line 859: Line 1,116:
|-
|-
!Alcoholism
!Alcoholism
|[[Macrocytic anemia|Macrocytic]]
|
* [[Macrocytic anemia|Macrocytic]]
| --
| --
| --
| --
|Anisochromic
|
|↑(Increased)
* Anisochromic
|↑(Increased)
|
|Normal
* ↑(Increased)
|
* ↑(Increased)
|
* Normal
|
|
* [[Memory impairment]]
* [[Memory impairment]]
Line 882: Line 1,144:
*  
*  
|<nowiki>--</nowiki>
|<nowiki>--</nowiki>
|Normal
|
|↑(Increased)
* Normal
|↑(Increased)
|
|↓(Decreased)
* ↑(Increased)
|↑(Increased)
|
|↑(Increased)
* ↑(Increased)
|
* ↓(Decreased)
|
* ↑(Increased)
|
* ↑(Increased)
|
|
* [[Macrocyte|Oval macrocytes]]
* [[Macrocyte|Oval macrocytes]]
* [[Neutrophil|Hypersegmented neutrophils]]
* [[Neutrophil|Hypersegmented neutrophils]]
|}
|}


{| class="wikitable"
{| class="wikitable"

Latest revision as of 20:56, 26 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2], Irfan Dotani [3]

Overview

A variety of conditions comprise the differential diagnosis of autoimmune hemolytic anemia. These include microangiopathic hemolytic anemia, paroxysmal cold hemoglobinuria, paroxysmal nocturnal hemoglobinuria, hereditary spherocytosis, pernicious anemia, and chronic lymphocytic leukemia. The diagnosis of autoimmune hemolytic anemia can sometimes be made by first ruling out these other causes. It is important to distinguish amongst these conditions since the prognosis and treatment of each condition is different.

Differentiating Autoimmune hemolytic anemia from other Diseases

Type of anemia MCV Hemolysis Intrinsic/Extrinsic Hb concentration RDW Reticulocytosis Haptoglobin levels Specific Symptoms Specific History Physical examination Genetics Iron studies Specific finding on blood smear
Hepcidin Serum iron Serum Tfr level Transferrin or TIBC Ferritin % Transferrin saturation
Autoimmune hemolytic anemia
  • Extrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
Associated with:
  • SLE
  • CLL
  • Mycoplasia pneumoniae infection
  • Painful, blue fingers and toes with cold weather
--
  • Normal
  • ↓(Decreased)
  • Normal
-- -- --
  • RBC agglutination
Iron deficiency anemia -- --
  • ↑(Increased)
  • Normal or ↓(Decreased)
  • Normal
--
  • Normal
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↓↓↓(Decreased)
Lead poisoning -- --
  • Normal
  • Normal or ↓(Decreased)
  • Normal
  • House painted with chipped paint
--
  • Normal
  • Normal or ↓(Decreased)
  • Normal
  • Normal
  • Normal or ↓(Decreased)
--
  • RBCs retain aggregates of rRNA (basophilic stippling)
Sideroblastic anemia -- --
  • Normal
  • Normal or ↓(Decreased)
  • Normal
  • Normal
  • ↑(Increased)
  • Normal
  • Normal or ↓(Decreased)
  • ↑(Increased)
--
Anemia of chronic disease -- --
  • Normal
  • Normal or ↓(Decreased)
  • Normal
-- --
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • ↓(Decreased)
  • ↑(Increased)
-- --
Thalassemia -- --
  • Normal
  • Thalassemia trait

Normal or ↓(Decreased)

  • Thalassemia Syndromes

↑(Increased)

  • Normal
α-thalassemia

β-thalassemia

α-thalassemia
  • α- globin gene deletions
  • Cis deletions
  • Trans deletions

β-thalassemia

  • Normal
  • Normal to ↑(Increased)
  • Normal
  • Normal
  • ↑(Increased)
Normal to increased
  • Target cells
  • Anisopoikilocytosis
G6pd deficiency
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased) but usually causes resolution within 4-7 days
  • ↓(Decreased)
History of using
  • Sulfa drugs
  • Antimalarials
  • infections,
  • Fava Beans
  • ↓(Decreased)
  • Normal to ↑(Increased)
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↑(Increased)
Pyruvate Kinase deficiency
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • Skin ulcers
  • Splenomegaly of varying degree
  • Normal
  • ↑(Increased)
  • Normal
  • Normal
  • ↑(Increased)
--
  • Prickle cells
  • Polychromatophilic erythrocytes
Sickle cell anemia
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
Normal or moderately elevated
  • Normal
  • Normal
Normal or moderately elevated
  • ↓(Decreased)
  • Normal
HbC disease
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • Gallstones
  • Enlarged spleen
  • Glutamic acid–to-lysine mutation in

β-globin

  • Normal
  • Normal
  • Normal
  • Normal
  • ↓(Decreased)
--
  • Hemoglobin Crystals inside RBCs
  • Target cells
Paroxysmal nocturnal hemoglobinuria(PNH)[1][2]
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • PIGA gene mutations
  • Impaired synthesis of GPI anchor for decay-accelerating factor [DAF/CD55] and membrane inhibitor of reactive lysis [MIRL/CD59]
  • Normal
  • ↓(Decreased)
  • Normal
  • ↑(Increased)
  • ↓(Decreased)
-- --
Hereditary spherocytosis
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • ↓(Decreased)
  • Normal
  • ↑(Increased)
  • Normal
--
  • Small, round RBCs with less surface

area and no central pallor ( MCHC)

Microangiopathic hemolytic anemia[3]
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • Purpura
  • Confusion
  • Aphasia
  • Diplopia
Associated with
  • DIC
  • TTP
  • HUS
  • SLE
  • HELLP

syndrome

  • Hypertensive emergency
  • Numbness of an arm or hand
  • Jaundice
  • Pale conjunctiva
--
  • Normal
  • ↓(Decreased)
  • Normal
--
  • ↑(Increased)
--
  • Helmet cells
Macroangiopathic hemolytic anemia
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
Associated with
  • Prosthetic heart valves
  • Aortic stenosis
  • Signs of anemia
  • Complications of hemolysis
  • Decreased vascular volume
  • Autoimmune
  • Normal
  • ↓(Decreased)
  • Normal
-- -- --
  • Spherocytes or schistocytes
Infections
  • Intrinsic
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
Associated with
  • Malaria
  • Babesia
  • Fever
  • Signs of shock
  • Headache
--
  • Normal
  • Normal
  • Normal
-- -- --
  • Trophozoite
  • Maltese crosses
Iron deficiency anemia(Early) -- --
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Pica
  • Glossitis
  • Cheilosis
  • Koilonychia
  • Conjuctival pallor
  • Dry skin
--
  • Normal
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↓(Decreased)
  • Microcytosis
  • Pencil cells
  • Ellyptocytosis
  • Hypochromasia
Anemia of chronic disease -- --
  • Normal
Normal or ↓(Decreased)
  • Normal
  • History of:
    • Rheumatoid arthritis
    • SLE
    • Neoplastic disorders
    • Chronic kidney disease
-- --
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↓(Decreased)
  • Normocytic cells but may become microcytic
Aplastic anemia -- --
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Symptoms based on underlying condition
  • Constitutive expression of Tbet
  • Mutations in the perforin gene
  • Mutations in SAP gene
  • Normal
  • ↓(Decreased)
  • ↓(Decreased)
  • Normal
  • ↑(Increased)
  • ↓(Decreased)
Chronic kidney disease -- --
  • ↑(Increased)
Normal /↑(Increased)
  • Normal
--
  • ↑(Increased)
  • ↓(Decreased)
--
  • ↓(Decreased)
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
Folate deficiency -- --
  • Anisochromic
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Alcoholics
  • History of using drugs like methotrexate, trimethoprim and phenytoin
  • Low socioeconomic groups with poor nutrition
  • Older people
  • Pregnant and lactating women
  • Impaired DNA synthesis
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
Vitamin B12 deficiency -- --
  • Anisochromic
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Impaired DNA synthesis
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
Orotic aciduria -- --
  • Anisochromic
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Coma
  • Gastro-intestinal manifestation
  • Neurological manifestation
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
--
Fanconi anemia -- --
  • Anisochromic
  • ↑(Increased)
  • ↓(Decreased)
  • Normal
  • Significant for B\L short thumbs
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
  • Normal appearing WBC, RBC and Platelets
  • But the number is greatly reduced
Diamond-Blackfan anemia -- --
  • Anisochromic
--
  • ↓(Decreased)
  • Normal
Mutations in:
  • RPL5
  • RPL11
  • RPL35A
  • RPS7
  • RPS10
  • RPS17
  • RPS19
  • RPS24
  • RPS26
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
--
Liver disease -- --
  • Anisochromic
  • ↑(Increased)
  • ↑(Increased)
  • Normal
  • Hepatitis
  • Binge drinking
  • Gall bladder disease
--
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
Alcoholism -- --
  • Anisochromic
  • ↑(Increased)
  • ↑(Increased)
  • Normal
--
  • Normal
  • ↑(Increased)
  • ↑(Increased)
  • ↓(Decreased)
  • ↑(Increased)
  • ↑(Increased)
Characteristic Causes Pathophysiology Laboratory abnormalities Physical examination Therapy Other associations
Autoimmune hemolytic anemia
  • Polyclonal antibody production that binds to and targets red blood cells for destruction intravascurly or extravascularly[4]
  • Removal of offending agent
  • Corticosteroids
  • Cyclophosphamide
  • Cyclosporine A
  • Azathioprine
  • Rituximab
  • Splenectomy
  • Hemolysis can occur at warm or cold temperatures
Microangiopathic hemolytic anemia
  • Formation of small vessel microthombi
  • Bleeding
  • Thrombosis
  • Pyrexia
  • Altered mental status
  • Neurologic deficits
  • Impaired urine output
  • Can be life-threatening pending the underlying cause
  • TTP required immediate treatment
Paroxysmal cold hemoglobinuria
  • Biphasic hemolysin (IgG) that binds red blood cells and low temperatures and triggers complement-mediated intravascular hemolysis at warm temperatures[5]
  • Associated with syphilis[5]
  • Maternal IgG can cross the placenta and affect the fetus[5]
Paroxysmal nocturnal hemoglobinuria
  • Genetic defect in anchoring proteins for complement factors on red blood cells
  • Hemolysis due to loss of complement inhibition on the red blood cell surface, which in turn is due to defect in CD55 (decay accelerating factor) and CD59 (membrane inhibitor of reactive lysis) or other glycophosphatidylinositol-anchored proteins on the red blood cell membrane
  • Absence of CD55 and CD59 by flow cytometry
  • Splenomegaly
  • Abdominal tenderness
  • Pallor
Hereditary spherocytosis[6]
  • Mutation in ankyrin[6]
  • Mutation in alpha- or beta-spectrin[6]
  • Mutation in band 3[6]
  • Mutation in protein 4.2[6]
  • Positive eosin-5-maleimide binding to red blood cells[6]
  • Positive osmotic fragility testing[6]
  • Spherocytes on peripheral blood smear
  • Can be autosomal dominant or recessive
Pernicious anemia[7]
  • Autoimmune gastritis[7]
  • Production of anti-intrinsic factor antibodies[7]
  • Production of anti-parietal cell antibodies[7]
  • Impaired vitamin B12 absorption due to absence of intrinsic factor
  • Low vitamin B12 level
  • Presence of anti-intrinsic factor antibodies
  • Presence of anti-parietal cell antibodies
  • Associated with diabetes, thyroid disease, vitiligo and other autoimmune conditions
Chronic lymphocytic leukemia[8]
  • Mutations in hematopoietic stem cells and B lymphocytes
  • Clonal proliferation of malignant B lymphocytes
  • Elevated absolute lymphocyte count
  • Anemia (Rai stage III) and thrombocytopenia (Rai stage IV)
  • Chemotherapy with rituximab
  • Ibrutinib
  • Venetoclax
  • Secondary autoimmune hemolytic anemia occurs in 10-25% of patients with CLL
  • Treatment with corticosteroids or anti-leukemic therapy will correct the underlying anemia

References

  1. Bunyaratvej A, Butthep P (January 1992). "Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes". J Med Assoc Thai. 75 Suppl 1: 237–42. PMID 1402472.
  2. Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K (January 2015). "A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data". Ann Lab Med. 35 (1): 35–40. doi:10.3343/alm.2015.35.1.35. PMC 4272963. PMID 25553278.
  3. Morishita E (July 2015). "[Diagnosis and treatment of microangiopathic hemolytic anemia]". Rinsho Ketsueki (in Japanese). 56 (7): 795–806. doi:10.11406/rinketsu.56.795. PMID 26251142.
  4. 4.0 4.1 4.2 Berentsen S, Sundic T (2015). "Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy". Biomed Res Int. 2015: 363278. doi:10.1155/2015/363278. PMC 4326213. PMID 25705656.
  5. 5.0 5.1 5.2 5.3 Akpoguma AO, Carlisle TL, Lentz SR (2015). "Case report: paroxysmal cold hemoglobinuria presenting during pregnancy". BMC Hematol. 15: 3. doi:10.1186/s12878-015-0023-7. PMC 4334594. PMID 25699184.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 Gallagher PG (2013). "Abnormalities of the erythrocyte membrane". Pediatr Clin North Am. 60 (6): 1349–62. doi:10.1016/j.pcl.2013.09.001. PMC 4155395. PMID 24237975.
  7. 7.0 7.1 7.2 7.3 7.4 Chan CQ, Low LL, Lee KH (2016). "Oral Vitamin B12 Replacement for the Treatment of Pernicious Anemia". Front Med (Lausanne). 3: 38. doi:10.3389/fmed.2016.00038. PMC 4993789. PMID 27602354.
  8. Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG; et al. (2017). "Chronic lymphocytic leukaemia". Nat Rev Dis Primers. 3: 16096. doi:10.1038/nrdp.2016.96. PMC 5336551. PMID 28102226.


Template:WikiDoc Sources